Breast cancer and spironolactone: an observational postmarketing study
ConclusionThis study did not find evidence for breast cancer associated with spironolactone.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Drugs & Pharmacology | International Medicine & Public Health | Spironolactone | Study | WHO | Women